- Home
- SWK vs SMMT Comparison
SWK vs SMMT Comparison
Compare SWK & SMMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWK
- SMMT
- Stock Information
- Founded
- SWK 1843
- SMMT 2003
- Country
- SWK United States
- SMMT United States
- Employees
- SWK N/A
- SMMT N/A
- Industry
- SWK Industrial Machinery/Components
- SMMT Biotechnology: Pharmaceutical Preparations
- Sector
- SWK Consumer Discretionary
- SMMT Health Care
- Exchange
- SWK Nasdaq
- SMMT Nasdaq
- Market Cap
- SWK 13.8B
- SMMT 14.5B
- IPO Year
- SWK N/A
- SMMT N/A
- Fundamental
- Price
- SWK $89.25
- SMMT $19.00
- Analyst Decision
- SWK Hold
- SMMT Strong Buy
- Analyst Count
- SWK 7
- SMMT 4
- Target Price
- SWK $98.57
- SMMT $34.75
- AVG Volume (30 Days)
- SWK 2.2M
- SMMT 2.1M
- Earning Date
- SWK 10-29-2024
- SMMT 10-30-2024
- Dividend Yield
- SWK 3.67%
- SMMT N/A
- EPS Growth
- SWK N/A
- SMMT N/A
- EPS
- SWK N/A
- SMMT N/A
- Revenue
- SWK $15,381,700,000.00
- SMMT N/A
- Revenue This Year
- SWK N/A
- SMMT N/A
- Revenue Next Year
- SWK $1.60
- SMMT N/A
- P/E Ratio
- SWK N/A
- SMMT N/A
- Revenue Growth
- SWK N/A
- SMMT N/A
- 52 Week Low
- SWK $77.70
- SMMT $1.89
- 52 Week High
- SWK $110.88
- SMMT $33.89
- Technical
- Relative Strength Index (RSI)
- SWK 39.72
- SMMT 46.02
- Support Level
- SWK $84.73
- SMMT $18.03
- Resistance Level
- SWK $87.17
- SMMT $20.14
- Average True Range (ATR)
- SWK 2.53
- SMMT 1.34
- MACD
- SWK 0.20
- SMMT -0.19
- Stochastic Oscillator
- SWK 37.60
- SMMT 21.56
About SWK Stanley Black & Decker Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.
About SMMT Summit Therapeutics Inc.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.